Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptose Biosciences, Inc. - Common Shares (NQ: APTO )

1.710 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.710
Bid (Size) 2.160 (153)
Ask (Size) 2.170 (10)
Prev. Close 1.710
Today's Range 1.710 - 1.710
52wk Range 1.710 - 38.34
Shares Outstanding 93,653,662
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aptose Announces Auditor Not Standing for Re-Appointment
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
From Aptose Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-75.80%
-75.80%
1 Month
-51.97%
-51.97%
3 Month
-72.71%
-72.71%
6 Month
-85.61%
-85.61%
1 Year
-95.37%
-95.37%

More News

Read More
What's going on in today's after hours session
Via Chartmill
What's going on in today's after hours session
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Via Chartmill
Top movers in Tuesday's session
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
Nasdaq Surges 1%; US Construction Spending Rises In February
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Why Aptose Biosciences (APTO) Stock Is Down Over 40%
Via Benzinga
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March
Via Benzinga
Topics Stocks
Exposures US Equities
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Reports Year End 2024 Results and Corporate Highlights
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
From Aptose Biosciences, Inc.
Via GlobeNewswire
What's going on in today's session
Via Chartmill
Here are the top movers in Wednesday's session.
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session.
Via Chartmill
Thursday's session: most active stocks
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
Top movers in Thursday's session
Via Chartmill
Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday?
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort
From Aptose Biosciences, Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session.
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.